1.Atezolizumab Plus Chemotherapy vs. Chemotherapy in Advanced or Metastatic Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis
Liu, XY, Lang, YT, L
More...
Liu, XY, Lang, YT, Liao, YH, Zhu, YZ
Less
FRONTIERS IN PUBLIC HEALTH[2296-2565],
Published 2021,
Volume 9,
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 3
2022影響因子:
5.2
发表年影響因子:
6.461